BioSpace News Archive

Swift Health Systems, Inc., makers of INBRACE®, today announced the company has raised $45MM in series C funding to help bolster commercialization of INBRACE.

Retail expansion increases accessibility of healthcare technology and support for people with chronic conditions such as diabetes and hypertension [08-October-2019] NEW YORK , Oct. 8, 2019 /PRNewswire/ -- One Drop, a leader in digital therapeutics solutions for diabetes and other chronic conditions, today announced that its wireless glucose meter kit and supplies are

Due to substantial and continued growth in its US and international business, Hyde Engineering and Consulting, Inc (Hyde) is pleased to announce a restructure of its executive leadership team.

The public awareness campaign, created by Leo Burnett, encourages employees to access company mental health resources

Nicki Beekman, PCHA as Executive Director, Kimberly Clynes as Director of Nursing and Ceridwen Kelley as Assistant Director of Nursing.

Honoring Kidney Community Excellence - AAKP Medal of Excellence Award

Introduction of Orbital Atherectomy Expands Treatment Options for Patients with Peripheral Artery Disease

While Both iStent and iStent inject Showed Significant IOP and Medication Reduction in Combo-Cataract Procedures at 1 Year Postoperative, iStent inject Achieved Greater Absolute IOP Declines with 93% of Subjects Medication-Free vs. 76% of iStent Subjects

Bill Leonard, President and Chief Executive Officer and Erns Loubser, Chief Financial Officer, will host a conference call at 10:00 a.m. (Eastern Time) on November 5, 2019 to discuss the financial results for the quarter.